| Title |
The use of preimplantation genetic testing for aneuploidy (PGT-A): a committee opinion
|
|---|---|
| Published in |
Fertility & Sterility, March 2018
|
| DOI | 10.1016/j.fertnstert.2018.01.002 |
| Pubmed ID | |
| Authors |
Practice Committees of the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology, Alan Penzias, Kristin Bendikson, Samantha Butts, Christos Coutifaris, Tommaso Falcone, Gregory Fossum, Susan Gitlin, Clarisa Gracia, Karl Hansen, Andrew La Barbera, Jennifer Mersereau, Randall Odem, Richard Paulson, Samantha Pfeifer, Margareta Pisarska, Robert Rebar, Richard Reindollar, Mitchell Rosen, Jay Sandlow, Michael Vernon, Eric Widra |
| Abstract |
The value of preimplantation genetic testing for aneuploidy (PGT-A) as a screening test for in vitro fertilization (IVF) patients has yet to be determined. Several studies demonstrate higher birth rates after aneuploidy testing and elective single-embryo transfer (eSET), suggesting the potential for this testing to decrease the risk of multiple gestations, though these studies have important limitations. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | 33% |
| United States | 1 | 33% |
| Unknown | 1 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 307 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 307 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 44 | 14% |
| Student > Master | 40 | 13% |
| Other | 27 | 9% |
| Student > Bachelor | 23 | 7% |
| Student > Ph. D. Student | 22 | 7% |
| Other | 55 | 18% |
| Unknown | 96 | 31% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 100 | 33% |
| Biochemistry, Genetics and Molecular Biology | 47 | 15% |
| Agricultural and Biological Sciences | 19 | 6% |
| Nursing and Health Professions | 11 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | <1% |
| Other | 24 | 8% |
| Unknown | 103 | 34% |
Attention Score in Context
This research output has an Altmetric Attention Score of 76. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 June 2022.
All research outputs
#560,144
of 25,382,440 outputs
Outputs from Fertility & Sterility
#225
of 9,377 outputs
Outputs of similar age
#12,911
of 344,853 outputs
Outputs of similar age from Fertility & Sterility
#3
of 64 outputs
Altmetric has tracked 25,382,440 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 9,377 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.1. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 344,853 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 64 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.